COHANCE — Cohance Lifesciences Share News
0.000.00%
Last trade - 00:00- IN₹172.11bn
- IN₹174.06bn
- IN₹22.69bn
Brief: Suven Pharmaceuticals Appoints Himanshu Agarwal As Chief Financial Officer
India's Suven Pharma rallies to over 1.5-yr high
Brief: India's Suven Pharmaceuticals Ltd Sept-Quarter Consol Net Profit Rises
Brief: Suven Pharmaceuticals Named Sudhir Kumar Singh As CEO
Brief: Suven Pharmaceuticals Says Ministry Of Chemicals And Fertilizers Granted Approval For Acquisition Of Up To 76.1% Stake In Co By Berhyanda
Brief: Cabinet Approves Foreign Investment Of Up To 95.89 Billion Rupees In Suven Pharmaceuticals - India Government
Brief: Suven Pharmaceuticals June-Qtr Consol Net Profit 1.21 Bln Rupees
Brief: India Government Says Competition Regulator Approves Acquisition Of 76.10% Stake In Suven Pharmaceuticals By Berhyanda
India's private equity investments fell 23.4% in 2022 - S&P
Brief: Suven Pharmaceuticals Dec-Quarter Consol Net Profit Falls
India's Suven Pharma rises as Advent to buy stake
Brief: Suven Pharmaceuticals Says Berhyanda Ltd, Berhyanda Midco Ltd, Jusmiral Midco Announced Open Offer To Buy 26% Stake In Co
Brief: Suven Pharmaceuticals Says Promoter Jasti Property And Equity Holdings Cuts Stake In Co To 9.9%
Advent to buy 'significant' stake in India's Suven Pharma, explore merger (updated)
Advent International to acquire significant stake in India's Suven Pharma
Brief: Advent International To Acquire A Significant Stake In Suven Pharmaceuticals From Jasti Family
Brief: India's Suven Pharmaceuticals Sept-Quarter Net Profit Falls
Media: Blackstone, Advent in talks to buy stake in Suven Pharma - Mint
Brief: Suven Pharmaceuticals' Unit Casper Pharma Receives EIR From USFDA For Pre-Approval Inspection